Universal Cells
Sarah Saxton is a Scientist at Universal Cells. Prior to this role, Sarah worked as a Postdoctoral Researcher at the University of Washington and as a Research Technician at Massachusetts Institute of Technology. Sarah also has experience as an Undergraduate Researcher at the University of California, Berkeley. Sarah holds a PhD in Bioengineering and Biomedical Engineering from the University of Washington and a BS in Bioengineering and Biomedical Engineering from the University of California, Berkeley.
Universal Cells
Universal Cells is a Seattle-based biotech developing, licensing and commercializing stem cell therapies that overcome immune rejection and can be used to create true off-the-shelf therapeutic products. Using the company's proprietary genome editing approach, the company engineers stem cells to prevent expression of polymorphic human leukocyteantigen (HLA) molecules, removing the cause of donor tissue rejection and creating Universal Donor Stem Cells that are compatible with every patient.